94 related articles for article (PubMed ID: 30542994)
1. Mutagenesis Screens for Prostate Cancer Using Replication-Incompetent Lentiviral Vectors.
Trobridge GD
Methods Mol Biol; 2019; 1907():103-114. PubMed ID: 30542994
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.
Nalla AK; Williams TF; Collins CP; Rae DT; Trobridge GD
Mol Carcinog; 2016 Nov; 55(11):1761-1771. PubMed ID: 26512949
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to identify driver genes involved in androgen-independent prostate cancer.
Schinke EN; Bii V; Nalla A; Rae DT; Tedrick L; Meadows GG; Trobridge GD
Mol Cancer; 2014 May; 13():120. PubMed ID: 24885513
[TBL] [Abstract][Full Text] [Related]
4. Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.
Bii VM; Collins CP; Hocum JD; Trobridge GD
Oncotarget; 2018 Mar; 9(21):15451-15463. PubMed ID: 29643985
[TBL] [Abstract][Full Text] [Related]
5. Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors.
Bii VM; Trobridge GD
Cancers (Basel); 2016 Oct; 8(11):. PubMed ID: 27792127
[TBL] [Abstract][Full Text] [Related]
6. Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter.
Yu D; Jia WW; Gleave ME; Nelson CC; Rennie PS
Prostate; 2004 Jun; 59(4):370-82. PubMed ID: 15065085
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
[TBL] [Abstract][Full Text] [Related]
8. Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression.
Kim JH; Lee H; Shin EA; Kim DH; Choi JB; Kim SH
Expert Opin Ther Targets; 2017 Sep; 21(9):911-920. PubMed ID: 28816549
[TBL] [Abstract][Full Text] [Related]
9. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
[TBL] [Abstract][Full Text] [Related]
10. [Literature-mining and bioinformatic analysis of androgen-independent prostate cancer-specific genes].
Li TQ; Feng CQ; Zou YG; Shi R; Liang S; Mao XM
Zhonghua Nan Ke Xue; 2009 Dec; 15(12):1102-7. PubMed ID: 20180422
[TBL] [Abstract][Full Text] [Related]
11. [Screening of membrane antigen differentially expressed in androgen-dependent prostate cancer and androgen-independent prostate cancer].
Zhang X; Tang Z; Qi L; Chen H; Luo Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):817-23. PubMed ID: 22954909
[TBL] [Abstract][Full Text] [Related]
12. Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A.
Zheng JY; Chen D; Chan J; Yu D; Ko E; Pang S
Cancer Gene Ther; 2003 Oct; 10(10):764-70. PubMed ID: 14502229
[TBL] [Abstract][Full Text] [Related]
13. [Current opinions on the treatment of androgen-independent prostate cancer].
Guan XX; Chen LB
Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1021-5. PubMed ID: 17146932
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
[TBL] [Abstract][Full Text] [Related]
15. Bad expression influences time to androgen escape in prostate cancer.
Teo K; Gemmell L; Mukherjee R; Traynor P; Edwards J
BJU Int; 2007 Sep; 100(3):691-6. PubMed ID: 17542986
[TBL] [Abstract][Full Text] [Related]
16. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms.
Schröder FH
Eur Urol; 2008 Jun; 53(6):1129-37. PubMed ID: 18262723
[TBL] [Abstract][Full Text] [Related]
17. The role of c-Jun and c-Fos expression in androgen-independent prostate cancer.
Edwards J; Krishna NS; Mukherjee R; Bartlett JM
J Pathol; 2004 Oct; 204(2):153-8. PubMed ID: 15378488
[TBL] [Abstract][Full Text] [Related]
18. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
[TBL] [Abstract][Full Text] [Related]
19. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
[TBL] [Abstract][Full Text] [Related]
20. A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration.
Pariente N; Morizono K; Virk MS; Petrigliano FA; Reiter RE; Lieberman JR; Chen IS
Mol Ther; 2007 Nov; 15(11):1973-81. PubMed ID: 17653099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]